FIELD: medicine, cardiology.
SUBSTANCE: additionally to conventional antiarhythmic preparations - amiodaron and bisoprolol - one should introduce atorvastatin at the daily dosage of 10 mg daily. The innovation enables to achieve stable clinical remission and decreases side effects due to the ability of atorvastatin to decrease the duration of Q-T interval and increase inotropic myocardial function.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
METHOD FOR PREVENTION OF ATRIAL FIBRILLATION IN OPEN LUNG SURGERIES OF ONCOLOGY DISEASES | 2014 |
|
RU2574187C1 |
METHOD OF TREATING PAROXYSMAL FORM OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC HEART FAILURE IN ARTERIAL HYPERTENSION | 2019 |
|
RU2703517C1 |
METHOD FOR PREVENTION OF RECURRENT ATRIAL FIBRILLATION FOLLOWING CARDIOSURGICAL OPERATIONS | 2014 |
|
RU2567920C1 |
METHOD OF TREATING ATRIAL FIBRILLATION | 2020 |
|
RU2728715C1 |
METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
METHOD FOR STUDYING HEART RATE VARIABILITY WITH UNDERLYING ANTIARRHYTHMIC THERAPY | 2018 |
|
RU2707263C2 |
METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
METHOD OF TREATING CARDIOVASCULAR PATIENTS AFTER SUFFERING ACUTE CORONARY SYNDROME AND CARDIOSURGICAL INTERVENTIONS | 2019 |
|
RU2715209C1 |
DESETHYLAMIODARONE COMPOSITIONS | 2013 |
|
RU2703312C2 |
Authors
Dates
2008-03-27—Published
2006-04-21—Filed